MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 601–700 of 828
HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma
Badami, E., Carcione, C., Chinnici, C. M., Tinnirello, R., Conaldi, P. G., & Iannolo, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.803278 · Cited by 9
“Both miRNAs are involved at various levels with senescence (22), stemness (23) and neoplastic progression (24).”
BackgroundInduction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation
Mathis, B. J., Kato, H., & Hiramatsu, Y. (2022) · Cells · doi:10.3390/cells11233855 · Cited by 9
“ProHypertrophic miRNA-15b/107 Decreases hypoxia response; targets BCL2, ARL2, PDK4, and SGK1 [105,120,121] miRNA-21 Pancellular expression; Interacts with PTEN, TPM1, PDCD4 [105,122] miRNA-23a Suppresses p53, BAX/BCL2, and PTEN [105,123] miRNA-27a-3p Targets NOVA1 to induce hypertrophy [105,124] miRNA-34 Targets PNUTS…”
BackgroundDanlou tablet inhibits high-glucose-induced cardiomyocyte apoptosis via the miR-34a-SIRT1 axis
Chen, R., Chen, H., Yang, Z., Zhu, L., Bei, Y., Chen, W., & Qiu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14479 · Cited by 11
Joshua, J., Caswell, J., Rodríguez, J. M. M., Kipar, A., O’Sullivan, M. L., Wood, G. A., & Fonfara, S. (2023) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2023.100037 · Cited by 10
“Similarly, miR-34 is highly expressed in mouse hearts [47,48].”
Conceptos actuales sobre el envejecimiento y la enfermedad cardiovascular
López, C. P., Jaramillo-Gómez, N., Mejía, C. A. V., Cardona-Vélez, J., Contreras-Martinez, H. J., & Restrepo, V. J. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2015.12.006 · Cited by 20
“…Sirt1 Nox4 Pten, Hmga2 Hmga2 Col1A1, Col3A1, Elastin Atm Boehm et al. (2005), Ibanez-Ventoso et al. (2006) Kato et al. (2011), Yang et al. (2013), Boon et al. (2013), Ito et al. (2010), Tabuchi et al. (2012), Xu et al. (2012) Vora et al. (2013) Van Almen et al. (2011) Jazbutyte et al. (2013)…”
Role of Non-Coding Variants in Brugada Syndrome
Pérez-Agustín, A., Pinsach‐Abuin, M., & Pagans, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228556 · Cited by 9
MiR-181b serves as diagnosis and prognosis biomarker in severe community-acquired pneumonia
Li, Q., Wu, T., & Li, S. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0431 · Cited by 9
“For instance, cardiac aging induced overexpression of miR34a, miR-34a regulated cardiac contractile function during aging by targeting PNUTS (Boon et al., 2013).”
Shah, V., & Shah, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.835138 · Cited by 9
“Anti-miR-34a in adult mice has been shown to reduce fibrosis and necrosis post-myocardial infarction additionally boosts cardiac regeneration andmyocardial function (95, 96).”
BackgroundNoncoding RNAs and Cardiac Fibrosis
Chang-yong, W., Bao, S., Li, R., Sun, H., & Peng, Y. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2402063 · Cited by 8
“MiR-34a-targeting PNUTS induced the DNA damage response and telomere shortening to improve functional recovery after acute myocardial infarction (AMI) [20].”
BackgroundWeiß, E., Schrüfer, A., Tocantins, C., Diniz, M. S., Novakovic, B., van Bergen, A. S., Kulovic‐Sissawo, A., Saffery, R., Boon, R. A., & Hiden, U. (2023) · The Journal of Physiology · doi:10.1113/jp284871 · Cited by 8
Self-citationWang, Z., Zhang, X., Li, W., & Yang, B. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2967-8 · Cited by 9
“…markers of DNA damage and protected cardiomyocytes from apoptosis by preventing telomere shortening and promoting the DNA damage response (Boon et al., 2013). miR-155: miRNA profiling identified miR-155 as the most down-regulated miRNAs with vascular aging (DuPont et al., 2016). miR-155…”
InfluentialExercise and the hallmarks of cardiovascular aging
Zhong, D., Fernández‐Garcia, B., Gokulnath, P., Lin, K., Li, G., Kroemer, G., López-Otín, C., & Xiao, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103030 · Cited by 12
Bevere, M., Cola, G. D., Santangelo, C., Grazioli, E., Marramiero, L., Pignatelli, P., Bondi, D., & Mrakic‐Sposta, S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac167 · Cited by 10
LncRNA NAV2-AS2 is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis
Rong, R., Yuan, T., Yan, Z., Tan, L., Wei, X., Li, G., Gao, H., Zhang, J., Zhao, X., Zhang, Z., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141400 · Cited by 8
Desregulated microRNAs in aging-related heart failure
Zhuo, R., Fu, S., Li, S., Yao, M.-C., Lv, D., Xu, T., & Bei, Y. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00186 · Cited by 8
“More recently, it was demonstrated that aginginduced expression of miR-34a and inhibition of its target PNUTs lead to increased cardiomyocyte death and reduced cardiac contractility function, by inducing telomere shortening and DNA damage responses (Boon et al., 2013).”
BackgroundNovel biomarkers to assess the risk for acute coronary syndrome: beyond troponins
Piccioni, A., Valletta, F., Zanza, C., Esperide, A., & Franceschi, F. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02422-z · Cited by 8
Reactive Oxygen Species-Mediated Diabetic Heart Disease: Mechanisms and Therapies
Reily-Bell, M., Bahn, A., & Katare, R. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0098 · Cited by 10
MiR-34a and endothelial biology
Li, Q., & Zhang, Q. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121976 · Cited by 9
Ooi, J. Y. Y., Bernardo, B. C., & McMullen, J. R. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.12.01 · Cited by 8
“, MI, pressure overload, dilated cardiomyopathy and atrial fibrillation), and targeting these miRNAs was effective in preventing or attenuating fibrosis in vivo (5,7-14).”
BackgroundEpigenética en la arteriosclerosis
Guardiola, M., Vallvé, J.-C., Zaina, S., & Ribalta, J. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.04.002 · Cited by 14
Vascular calcification; Stony bridge between kidney and heart
Zaker, B., & Ardalan, M. (2020) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.2020.29 · Cited by 8
Novel molecular therapeutic targets in cardiac fibrosis: a brief overview
Wang, R., Lin, J. J., & Bagchi, R. A. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0430 · Cited by 8
“The miR-34 family, containing miR-34a, b, and c, has been implicated in several aspects of cardiac physiology such as cell survival and proliferation, angiogenesis, and ageing, and are highly expressed in cardiomyocytes and non-cardiomyocytes (Boon et al. 2013; Yang et al. 2015).”
BackgroundSynthetic Design of Asymmetric miRNA with an Engineered 3′ Overhang to Improve Strand Selection
Kadekar, S., Nawale, G. N., Karlsson, K., Ålander, C., Oommen, O. P., & Varghese, O. P. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.04.012 · Cited by 8
“types of cancer,(10,17,27) osteoporosis, and bone metastasis(28) as well as in cardiovascular diseases.(22) Interestingly, some studies with miR34a also indicated dual strand activity, which would allow us to quantify the role of miR or miR* strands separately.”
BackgroundLock, M. C., Tellam, R. L., Darby, J. R. T., Soo, J. Y., Brooks, D. A., Seed, M., Selvanayagam, J. B., & Morrison, J. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00614 · Cited by 9
“The inhibition of miR-34 family members has shown therapeutic potential, where cardiac remodeling was attenuated and improved cardiac function in mouse models of both pressure overload and MI with up-regulation of growth factor target genes including Vegf, Vcl, Sirt1, Notch1, and Pofut1 (Bernardo et al., 2012; Boon et…”
BackgroundMicroRNAs in the Stressed Heart: Sorting the Signal from the Noise
Matkovich, S. J. (2014) · Cells · doi:10.3390/cells3030778 · Cited by 7
“Anti-miRs against miR-34a [98] and the miR-212/132 family [99] offer protection against cardiac pressure-overload while anti-miR-34 reagents also protect against age-dependent cardiac cell death and injury resulting from myocardial infarction [100]; an anti-miR-24 is able to improve the outcome of pressure-overload by…”
BackgroundRoll-to-Roll DNA Nanomachine for Ultrasensitive Electrochemical Determination of miRNA
Zhang, Z., Ma, X., Zhu, J., Yan, R., & Miao, P. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c02102 · Cited by 7
Rejuvenation of the Aging Heart: Molecular Determinants and Applications
Alibhai, F. J., & Li, R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.004 · Cited by 9
Tudurachi, B.-S., Anghel, L., Tudurachi, A., Sascău, R. A., Zanfirescu, R.-L., & Stătescu, C. (2024) · Biomedicines · doi:10.3390/biomedicines12061314 · Cited by 7
“In mice, PNUTS improves function recovery following a heart attack [103].”
Smart Engineering of a Self-Powered and Integrated Nanocomposite for Intracellular MicroRNA Imaging
Cui, M.-R., Li, X., Chen, H., & Xu, J. (2020) · CCS Chemistry · doi:10.31635/ccschem.020.202000419 · Cited by 7
Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Zia, A., Farkhondeh, T., Sahebdel, F., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210917141541 · Cited by 7
Kuai, Z., & Hu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16214 · Cited by 7
AntimiR-34a to Enhance Cardiac Repair After Ischemic Injury
Gladka, M. M., & van Rooij, E. (2015) · Circulation Research · doi:10.1161/circresaha.115.307066 · Cited by 7
Fibroblast Senescence and Apoptosis. “One-Two Punch” to Slow Down Lung Fibrosis?
Pardo, A., & Selman, M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0387ed · Cited by 7
Vasileiou, M., Liposits, G. I., Barakat, B., & Nguyen, N. P. (2026) · Aging Cell · doi:10.1111/acel.70518 · Cited by 6
The Effects of M2 Macrophages-Derived Exosomes on Urethral Fibrosis and Stricture in Scar Formation
Ren, X., Wang, Z., Wang, J., Xing, L., Wei, H., Liu, C., Liu, S., Zhu, Y., Feng, C., Yin, Y., et al. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s500499 · Cited by 7
“52–54 For example, miR-34a in the serum of patients with primary biliary cholangitis regulates the epithelium-mesenchymal transition and fibrosis via the TGF-β1/smad pathway.”
Generative Modelling of the Ageing Heart with Cross-Sectional Imaging and Clinical Data
Qiao, M., Basaran, B. D., Qiu, H., Wang, S., Guo, Y., Wang, Y., Matthews, P. M., Rueckert, D., & Bai, W. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-23443-9_1 · Cited by 6
Domínguez-de-Barros, A., Sirvent-Blanco, C., García-Pérez, O., Gajate-Arenas, M., García-Ramos, A., Migliazzo, C., Piñero, J. E., Lorenzo‐Morales, J., & Córdoba-Lanús, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104934 · Cited by 5
“…or apoptosis in cancerous processes [58]. miR-34 levels are increased in neurodegenerative disorders and age-related cardiovascular diseases [59,60]. miR-34a targets SIRT1 and reduces its expression, which is especially important as Sirtuin 1 protects against age-related diseases, especially…”
MicroRNA-34a: A New Piece in the Cardiac Aging Puzzle
Chiao, Y. A. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000277 · Cited by 6
Booth, S. A., Wadley, G. D., Marques, F. Z., Wlodek, M. E., & Charchar, F. J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00042.2018 · Cited by 6
“Protein phosphatase 1 regulatory subunit 10 (Ppp1r10, also known as Pnuts) can facilitate the binding of Trf2 and is protective of cardiac telomere length and apoptosis (12), but its involvement in exercise-induced hypertrophy is not known.”
BackgroundLi, Q., Ge, Z., Yin, X., Ding, T., Tang, Y. M., & Zhang, Y. (2022) · Free Radical Research · doi:10.1080/10715762.2021.1953004 · Cited by 6
“Recently, miR-34a was identified as a pivotal regulator in heart dysfunction and aging [15,24].”
BackgroundInfluentialMicroRNAs in Non-Malignant Diseases
Mirzaei, H., Rahimian, N., Mirzaei, H. R., Nahand, J. S., & Hamblin, M. R. (2022) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-79177-2_3 · Cited by 7
Vieillissement: Une question de cœur ?
Mialet‐Perez, J., Douin‐Echinard, V., Cussac, D., Bril, A., & Parini, A. (2015) · médecine/sciences · doi:10.1051/medsci/20153111015 · Cited by 8
Doxorubicin Cardiotoxicity: Multiple Targets and Translational Perspectives
Angelis, A. D., Cappetta, D., Berrino, L., & Urbanek, K. (2018) · InTech eBooks · doi:10.5772/intechopen.80057 · Cited by 7
“miRs have been associated with the regulation of myocardial cell proliferation and differentiation [70], and among others, the miR-34 family, particularly miR-34a, is expressed in the heart and is associated with DNA damage, and pro-senescent and pro-apoptotic mechanisms [71, 72].”
BackgroundTRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling
Li, S., Cao, W., Wang, B., Zhan, E., Xu, J. Y., & Li, S. (2020) · Clinical Science · doi:10.1042/cs20200249 · Cited by 6
RetractedPosttranscriptional Regulation by Proteins and Noncoding RNAs
Aránega, A. E., & Franco, D. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_17 · Cited by 6
Wang, Y., Yang, M., Wang, G., Liu, W., Deng, B., Yang, X., & Li, X. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5541 · Cited by 6
Cell-free strategies for cardiomyocyte proliferation and heart repair
Łoboda, A., Zieliński, T., & Dulak, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00805-7 · Cited by 5
“Boon et al. [40] hypothesized that the age-dependent decline in cardiac function may result from the disturbed expression of some microRNAs.”
The role of endogenous miRNAs in the development of cerebral aneurysms
Фанилевич, Г. И., & Сафин, Ш. М. (2019) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro201983011112 · Cited by 5
Feng, L., Wei, Y., Sun, Y., Zhou, L., Bi, S., Chen, W., & Xiang, W. (2023) · Aging · doi:10.18632/aging.204854 · Cited by 6
Abdel‐Reheim, M. A., Zaafar, D. K., El‐Shoura, E. A. M., Abdelaal, N., Atwa, A. M., Bazeed, S. M., & Mahmoud, H. M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111369 · Cited by 6
A Thorough Navigation of miRNA's Blueprint in Crafting Cardiovascular Fate
Nazir, A., Uwishema, O., Shariff, S., Franco, W. X. G., Masri, N. E., Ayele, N. D., Munyangaju, I., Alzain, F. E., & Wojtara, M. S. (2024) · Health Science Reports · doi:10.1002/hsr2.70136 · Cited by 6
“They play a major role in cardiogenesis through the stimulation of stem cell differentiation into mesodermal cells early in embryo development and later into cardio-myocytes [72].”
BackgroundInfluentialTime’s imprint on the left atrium: aging and atrial myopathy
Gyberg, D. J., Patel, R. B., & Zhang, M. J. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.23 · Cited by 7
“Similarly, mircoRNA-34a, which is also upregulated with age, contributes to age-related cardiac cell death and functional decline by inhibiting PNUTS, a regulator that protects against telomere shortening [99] .”
Endothelial miR-34a deletion guards against aneurysm development despite endothelial dysfunction
Kopacz, A., Klóska, D., Bar, A., Targosz‐Korecka, M., Cysewski, D., Awsiuk, K., Piechota-Polańczyk, A., Cichon, M., Chłopicki, S., Jozkowicz, A., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167812 · Cited by 5
(2015) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2015.03.00101 · Cited by 5
“In contrast, collagen synthesis increases in HTN and pressureoverload hypertrophy [130-132].”
BackgroundExploiting the hypoxia sensitive non-coding genome for organ-specific physiologic reprogramming
Bischof, C., & Krishnan, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.024 · Cited by 5
Reprint of: Aging: Treating the Older Patient
Rosko, A. E., & Artz, A. S. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.01.002 · Cited by 5
Non-coding microRNAs for cardiac regeneration: Exploring novel alternatives to induce heart healing
Garreta, E., Prado, P., Belmonte, J. C. I., & Montserrat, N. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.05.001 · Cited by 5
Aging Aorta—Cellular Mechanisms
Radu, F. I., Tintoiu, I., Rosu, A., Bontaş, E., Cochior, D., Bolohan, R., Silvestru, C., Ifrim, M., Mocanu, I., Riga, D., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809979-7.00001-8 · Cited by 5
A DNA encoding loop program: the snowball effect enhanced microRNA visualization in living cells
Lv, J. C., Zhou, Z., & Qian, R. (2019) · Chemical Communications · doi:10.1039/c9cc02169h · Cited by 5
Chen, P., Zhou, C., Li, B., & Yang, C. (2020) · PubMed Central · Cited by 8
Кочетов, А. Г., Lyang, O. V., Рашитович, Г. Р., Abramov, A. A., Жиров, И. В., Skvortsov, A. A., Zaseeva, A. V., Bosykh, E. G., Masenko, V. P., & Tereshchenko, S. N. (2016) · Laboratory Service · doi:10.17116/labs20165126-32 · Cited by 5
Жиров, И. В., Кочетов, А. Г., Zaseeva, A. V., Liang, O. V., Skvortsov, A. A., Abramov, A. A., Рашитович, Г. Р., Masenko, V. P., & Tereshchenko, S. N. (2016) · Systemic Hypertension · doi:10.26442/sg29129 · Cited by 5
Zivalj, D., Schleicher, L. M. S., Kršek, A., Diamee, H. J. F., Raljević, D., & Batičić, L. (2026) · Life · doi:10.3390/life16030400 · Cited by 7
Impact of Cellular Mechanisms of Ischemia on CABG Failure
Amuzescu, B. P., Istrate, B. M., & Mubagwa, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-26515-5_31 · Cited by 4
An Update on the Molecular Pillars of Aging
García‐Velázquez, L., & Arias, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_1 · Cited by 6
Dimitrakopoulos, G. Ν., Dimitrakopoulou, K., Maraziotis, I. A., Sgarbas, K., & Bezerianos, A. (2014) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2014.6943593 · Cited by 4
Noncoding RNAs in Cardiovascular Aging
Li, Y., Zhu, Y., Li, G., & Xiao, J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_3 · Cited by 4
Noncoding RNAs in the Cardiovascular System: Exercise Training Effects
Pereira, N. P., Gatto, C. D. V. G., de Oliveira, E. M., & Fernandes, T. M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.86054 · Cited by 4
“The miRNA-34 family (miRNA-34a, -34b, and -34c) expression levels are elevated in both hearts of mice with cardiac stress and in aging process, as well as in patients with HF [76, 77].”
BackgroundCarmona-Luque, M. D., Gonzalez-Alvarez, L., & Orriach, J. L. G. (2022) · Life · doi:10.3390/life13010064 · Cited by 4
“miRNAs have been proposed as an alternative to cell and gene therapies for cardiac regeneration [26,27]; however, these miRNA-based therapies still require clinical validation in models with greater translational potential [28,29].”
BackgroundRui, H., Yu, H., Zou, D., Chi, K., Xu, P., Song, X., Liu, L., Wu, X., Wang, J., & Xue, L. (2023) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000097 · Cited by 4
Epigenetic Mechanisms in Osteoporosis
Ostanek, B., Kranjc, T., Lovšin, N., Zupan, J., & Marc, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00018-8 · Cited by 4
Micrornas and Cardiovascular Diseases: From Bench to Bedside.
Rosa, R. D., Polito, M. V., Benvenga, R. M., Angelis, E. D., Piscione, F., & Galasso, G. (2017) · PubMed Central · Cited by 4
Acetylation in Cardiac Aging: Molecular Mechanism and Therapeutic Approaches
Hase, A. D., & Banerjee, S. (2025) · Results and problems in cell differentiation · doi:10.1007/978-3-031-91459-1_9 · Cited by 4
The Yin and Yang of cellular senescence in ischemia-induced myocardial injury
Gudenberg, R. W. V., Iske, J., Roeschl, T., Stawowy, P., Kirkland, J. L., Ruhparwar, A., & Tullius, S. G. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.12.004 · Cited by 6
Small Noncoding RNAs in Senescence and Aging
Dhahbi, J. M. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_15 · Cited by 4
Identifying Potential miRNA-Disease Associations Based on an Improved Manifold Learning Framework
Tang, Y., Li, G., Wu, Y., & Yi, D. (2020) · IEEE Access · doi:10.1109/access.2020.2972068 · Cited by 3
“During the post-transcriptional period, they repress gene expression by facilitating the degradation of the target mRNAs [5], thereby playing crucial roles in most cellular processes [6], [7], including cell division [8], differentiation [9], development, metabolism, infection, aging [10], apoptosis [11], and signal t…”
BackgroundMonroy‐Jaramillo, N., & Vázquez-Martínez, E. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_8 · Cited by 3
miR-9-5p promotes myogenic differentiation via the Dlx3/Myf5 axis
Dong, L., Wang, M., Gao, X., Zheng, X., Zhang, Y., Sun, L., Zhao, N., Ding, C., Ma, Z., & Wang, Y. (2022) · PeerJ · doi:10.7717/peerj.13360 · Cited by 3
“Previous studies have indicated that miRNAs can regulate skeletal muscle development (Li et al., 2018; Zhang et al., 2018), cardiac regeneration (Eulalio et al., 2012), aging and functions (Boon et al., 2013).”
BackgroundAging-regulated PNUTS maintains endothelial barrier function via SEMA3B suppression
Lozano‐Vidal, N., Stanicek, L., Bink, D. I., Juni, R. P., Hooglugt, A., Kremer, V., Phelp, P. G., van Bergen, A. S., MacInnes, A. W., Dimmeler, S., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06230-5 · Cited by 3
“Recently, we showed that PNUTS expression is markedly repressed in the heart during aging and CVD, and the mechanism by which PNUTS downregulation induces post-ischemic heart failure includes telomere attrition in cardiomyocytes, a hallmark of aging 21 .”
InfluentialSelf-citationMicroRNA-Linked Heart Disease and Therapeutic Potential
Ono, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800553-8.00010-x · Cited by 4
Therapeutic microRNA‐based strategies in cardiovascular disease discriminate sex and age difference
Tian, C., & Zucker, I. H. (2016) · The Journal of Physiology · doi:10.1113/jp272892 · Cited by 3
“Importantly, microRNA-34a inhibition reduced cell death and fibrosis following acute myocardial infarction and improved the recovery after myocardial infarction (Boon et al. 2013).”
BackgroundAging Heart: Recent Research and Concepts
Nikhra, V. (2017) · Gerontology & Geriatrics Studies · doi:10.31031/ggs.2017.01.000501 · Cited by 4
“The oxidative stress tends to be pervasive among cellular organelles and macromolecules, and the cumulative oxidative damage consequent to oxidative stress leading to inflammatory response at cellular and sub cellular levels, brings forth various aging-associated changes [23].”
BackgroundMolecular and Cellular Biology of the Right Heart
Amuzescu, B. P., & Maniu, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-73764-5_3 · Cited by 3
Oxidative Stress Reduction (Prong-3)
DePace, N. L., & Colombo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17016-5_5 · Cited by 3
Evolving targeted therapies for right ventricular failure
Salvo, T. G. D. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1054277 · Cited by 2
Zebrafish as a Model for Studying Cardiac Regeneration
Wu, C. C., & Weidinger, G. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0042-2 · Cited by 2
Plowright, A. T., Engkvist, O., Gill, A. L., Knerr, L., & Wang, Q. (2014) · Angewandte Chemie · doi:10.1002/ange.201307034 · Cited by 2
MicroRNA‐34a Mediates the Aldosterone‐Induced Acceleration of Endothelial Senescence
Jia, M., Lin, L., Yang, B., Yu, H., Zhong, S., Xu, X., & Song, X. (2025) · International Journal of Hypertension · doi:10.1155/ijhy/2339598 · Cited by 2
“Boon et al. found that silencing or gene knockdown of miR-34a can reduce the apoptosis of senescence-associated myocardial cells, and miR-34a inhibitors can reduce apoptosis and fbrosis after acute myocardial infarction, thereby improving myocardial function recovery [46].”
Exosome miR-152-3p derived from small intestinal epithelium modulates aging process in adipocytes
Di, W., Xue, C., Lin, Y., Zhang, W., & Zhou, Y. (2025) · 3 Biotech · doi:10.1007/s13205-025-04346-x · Cited by 2
“Ectopic overexpression of microRNA-34a (miR-34a) can induce cell cycle arrest, apoptosis, and aging (Boon et al. 2013; Liu et al. 2011).”
Iqbal, A., Ghani, M. W., Shao, N., Zhang, Y., Wang, Z., & Pei, R. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05476-9 · Cited by 2
Nanotechnology-driven heart targeting to fulfil the potential of cardiac microRNA therapies
Bellido, N. H., Hernández‐Ainsa, S., Köhler, R., & Ordovás, L. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126643 · Cited by 3
Mele, E. L. E. N. A., Riemma, M. A., Donniacuo, M., Telesca, M., Sorrentino, G., D’Amario, D., Scialò, F., Cianflone, E., Cappetta, D., Torella, D., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03133-z · Cited by 3
“Inhibition of miR-34a restores NAMPT and NAD ⁺ , improves metabolic parameters and recovers myocardial function reducing cell death and fibrosis in different models of myocardial injury [53, 65, 66].”
Kontaraki, J. E., Plevritaki, A., Sallo, A., Fragkiadakis, K., Kallergis, E. M., Zacharis, E. A., Kopidakis, J. K., Kampanieris, E., Achladianaki, S. A., Papakosta, V., et al. (2026) · Genes · doi:10.3390/genes17030356 · Cited by 3
“MiRNAs such as miR-34a, miR-320a, and miR-181b have been implicated in cardiomyocyte apoptosis, oxidative stress, and mitochondrial dysfunction in cardiovascular disease and heart failure cohorts [71–73].”
Vélez-Slimani, H., & Salazar, L. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083582 · Cited by 2
Aging Integromics: Module-Based Markers of Heart Aging from Multi-omics Data
Dimitrakopoulou, K., Vrahatis, A. G., Dimitrakopoulos, G. Ν., & Bezerianos, A. (2013) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-319-02913-9_27 · Cited by 2
Post-transcriptional Regulation by Proteins and Non-coding RNAs
Aránega, A. E., & Franco, D. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1883-2_13 · Cited by 2
Renin-Angiotensin System MicroRNAs, Special Focus on the Brain
Gerardo-Aviles, J., Allen, S. J., & Kehoe, P. G. (2017) · InTech eBooks · doi:10.5772/67080 · Cited by 2
“MiR-34 promotes endothelial senescence by downregulating the histone deacetylase sirtuin-1 [129] and regulates cardiac contractile function during ageing and after acute myocardial infarction, as a result of inducing DNA damage and telomere attrition [130].”
BackgroundMacrophages: new players in cardiac ageing?
Bruegmann, T., & Smith, G. L. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy047 · Cited by 2
Computational Methods for Identifying MicroRNA-Gene Regulatory Modules
Liu, Y. (2022) · Springer handbooks of computational statistics · doi:10.1007/978-3-662-65902-1_10 · Cited by 2
Regulation of ABCA1 by miR-33 and miR-34a in the Aging Eye
Peters, F., & Grimm, C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-27681-1_9 · Cited by 3
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.